[Gene therapy to cure HIV infection].
Thérapie génique pour guérir l’infection par le VIH.
HIV-1
U1 interfering RNA
aptamers
gene therapy
ribozymes
short hairpin RNAs
Journal
Virologie (Montrouge, France)
ISSN: 1267-8694
Titre abrégé: Virologie (Montrouge)
Pays: France
ID NLM: 9802575
Informations de publication
Date de publication:
01 Oct 2023
01 Oct 2023
Historique:
medline:
23
11
2023
pubmed:
22
11
2023
entrez:
22
11
2023
Statut:
ppublish
Résumé
To date, the only intervention that has cured HIV infection has been bone marrow transplants from HIV-resistant donors to HIV-infected recipients. This approach has been used to both cure hematological malignancies and HIV infection, but it cannot be widely adopted due to the high risk of mortality associated with cell transplants between individuals. To overcome this limitation, several approaches have been developed to generate HIV resistance using gene therapy in an infected individual's own cells. With the growing arsenal of effective methods to generate HIV-resistant cells, a safe and effective combination gene therapy approach to cure HIV infection is fast approaching. Here, we review several gene therapy-based methods to generate HIV-resistant cells including the expression of antiviral genes, genome editing, and transcriptional gene silencing. Their varied mechanisms, advantages, and disadvantages are discussed, and perspectives are provided for how they may be combined to design an effective gene therapy for HIV.
Identifiants
pubmed: 37991319
pii: vir.2023.1021
doi: 10.1684/vir.2023.1021
doi:
Types de publication
Review
English Abstract
Journal Article
Langues
fre
Sous-ensembles de citation
IM